SG Americas Securities
CLOV icon

SG Americas Securities’s Clover Health Investments CLOV Stock Holding History

SG Americas Securities’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
245,875
+102,116
+71% +$347K ﹤0.01% 1728
2026
Q1 		$253K Buy
143,759
+84,713
+143% +$184K ﹤0.01% 2536
2025
Q4 		$139K Buy
59,046
+30,223
+105% +$82.6K ﹤0.01% 3081
2025
Q3 		$88K Buy
28,823
+1,369
+5% +$3.91K ﹤0.01% 3109
2025
Q2 		$77K Buy
27,454
+596
+2% +$1.96K ﹤0.01% 2684
2025
Q1 		$96K Buy
+26,858
New +$108K ﹤0.01% 3063
2024
Q4 		– Sell
-89,236
Closed -$252K – 3201
2024
Q3 		$252K Buy
+89,236
New +$204K ﹤0.01% 2295
2023
Q2 		– Sell
-263,953
Closed -$223K – 2423
2023
Q1 		$223K Buy
263,953
+245,792
+1,353% +$269K ﹤0.01% 2342
2022
Q4 		$17K Sell
18,161
-49,432
-73% -$66K ﹤0.01% 2948
2022
Q3 		$115K Buy
67,593
+57,204
+551% +$150K ﹤0.01% 2752
2022
Q2 		$22K Buy
+10,389
New +$27.6K ﹤0.01% 3332
2021
Q3 		– Sell
-206,050
Closed -$2.75M – 3832
2021
Q2 		$2.75M Buy
206,050
+86,050
+72% +$845K 0.01% 932
2021
Q1 		$907K Buy
+120,000
New +$1.35M ﹤0.01% 1615

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SG Americas Securities's CLOV Position: Q2 2026 in Review

SG Americas Securities increased its Clover Health Investments (CLOV) stake by 71% in Q2 2026, buying an estimated $347K and bringing the position to 245,875 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1728.

SG Americas Securities first reported a position in CLOV in Q1 2021 and has held it in 13 quarters since. The position peaked at $2.75M in Q2 2021. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • SG Americas Securities held 245,875 shares of Clover Health Investments worth $1.29M as of Q2 2026.
  • SG Americas Securities bought 102,116 Clover Health Investments shares in Q2 2026, an estimated $347K.
  • Clover Health Investments made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1728 holding.
  • SG Americas Securities first reported a position in Clover Health Investments in Q1 2021 and has held it in 13 quarters since.
  • SG Americas Securities's Clover Health Investments position peaked at $2.75M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.